A recent clinical study has revealed that a structured three-year exercise program implemented soon after adjuvant chemotherapy significantly enhances disease-free survival in patients treated for colon cancer. The study provides promising evidence that physical activity may play a critical role in long-term cancer recovery and management.
Funded by the Canadian Cancer Society and other partners, the CHALLENGE trial (Colon Health and Life-Long Exercise Change) enrolled patients diagnosed with stage II or III colon cancer who had completed adjuvant chemotherapy. Participants were randomized into two groups: one receiving standard health education and the other undergoing a supervised and structured physical activity program for three years.
The results demonstrated a clear clinical benefit for those in the exercise group, with a statistically significant increase in disease-free survival. There were also findings suggestive of improved overall survival among those who participated in the exercise intervention, although that outcome requires further confirmation with ongoing follow-up.
Researchers noted that regular physical activity may positively influence immune function, reduce inflammation, and help manage body weight—all factors associated with reduced cancer recurrence.
These findings highlight the potential for integrating structured exercise programs into standard post-treatment care for colon cancer survivors. Clinicians and health systems may consider adopting similar models to support long-term recovery and improve patient outcomes.
The CHALLENGE trial is listed under ClinicalTrials.gov with the identifier NCT00819208.
Source: https:// – Courtesy of the original publisher.
